It would seem the below agreement does not exist. 20 July...

It would seem the below agreement does not exist.

20 July 2020

Respiri Signs Agreement with BNPL Provider ZIP – update

Respiri Limited (ASX:RSH)(“Respiri” or the “Company”), an eHealth SaaS Company supporting respiratory
health management, was pleased to announce this morning that it has executed a merchant services agreement
with a leading Buy Now Pay Later (BNPL) provider Zip Money Payments Pty Ltd, a wholly owned subsidiary of
Zip Co Limited (ASX:Z1P).
Further to this announcement the Company would like to clarify the importance of this agreement and its
significance to the imminent release of the Company’s revenue guidance.
The Zip agreement enables Respiri consumers to purchase wheezo® and pay over six interest-free monthly
instalments. The availability of this payment plan option removes a potential barrier for a portion of our target
customer base. As a result we expect higher customer uptake resulting in higher forecast revenues.
By taking advantage of the ZIP agreement customers will pay $14 per week (including SaaS subscription) for a
period of six months rather than an upfront price for device-only of $299. Based on prior experience of similar
offerings the impact of such a facility is expected to be an additional 10% in revenue over and above other
channels.
Respiri’s mission is help improve the quality of life of all asthma sufferers and the Company is committed to
ensuring wheezo® is available in a timely fashion to all customers.
The Company expects to provide revenue guidance for the 2021 calendar year within the next 5 business days.